09:47 AM EST - Avivagen Inc. : Concluded its fiscal year ended October 31, 2016 in a strong financial position, with cash and cash equivalents of $5,142,401, as compared to $632,247 at the end of fiscal 2015. Avivagen Inc.
shares V.VIV are trading down $0.005 at $0.12.